¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"acute papular onchodermatitis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • acute illness policy
    ±Þ¼ºÁúȯÁ¤Ã¥<--¹æÄ§>
  • acute inclusion body encephalitis
    ±Þ¼º ºÀÀÔü³ú¿°(¡­Üæìýô÷Òàæú).
  • acute infectious disease
    ±Þ¼º °¨¿°Áúȯ
  • acute infectious disease =AID
    ±Þ¼º Àü¿°º´(¡­îîæøÜ»).
  • acute infectious gastroenteritis =epidemic viral
    ±Þ¼ºÀü¿°¼ºÀ§Àå¿°(¡­îîæøêÖíóæú).
  • acute infectious gastroenteritis =epidermic viral g.
    ±Þ¼º Àü¿°¼º À§Àå¿°(¡­îîæøàõêÖ æú).
  • acute infectious hemorrhagic fever
    ±Þ¼º Àü¿°¼º ÃâÇ÷¿­(¡­îîæøàõõóúìæð).
  • acute infectious hemorrhagic fever
    ±Þ¼º°¨¿°¼ºÃâÇ÷¿­(õóúìæð)
  • acute infectious lymphocytosis
    ±Þ¼º Àü¿°¼º ¸²ÇÁ±¸ Áõ°¡Áõ.
  • acute inflammatory demyeliniating
    ±Þ¼º¿°Áõ¼ºÅ»¼öÃʼº(¡­æúñøàõ ÷­âÐÃÊàõ)
  • acute intermittent porphyria
    ±Þ¼º °£Ç漺 (?˧̴ËÛ) Æ÷¸£ÇǸ®¾Æ(Áõ).
  • acute intermittent porphyria
    ±Þ¼º °£Ç漺 (¡­ÊàúÎàõ) Æ÷¸£ÇǸ®¾Æ(Áõ).
  • acute intermittent porphyria
    ±Þ¼º °£Ç漺(Ðáàõ ÊàúÎàõ) Æ÷¸£ÇǸ°Áõ(~ ñø)
  • acute intermitternt porphyria
    ±Þ¼º °£Ç漺 Æ÷¸£ÇǸ®¾Æ(Áõ)
  • acute interstitial pneumonitis
    ±Þ¼º °£Áú¼º Æó·Å(¡­ÊàòõàõøËæú).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • acute hallucinatory paranoia
    ±Þ¼º ȯ»ó¼º ÆíÁýº´(Ðáàõü³ßÌàõø¶òûÜ»).
  • acute heart failure
    ±Þ¼º ½ÉºÎÀü(¡­ãýÝÕîï).
  • acute hemolytic anemia
    ±Þ¼º ¿ëÇ÷¼º ºóÇ÷(?ËíÌ´ËÛË×Ì´).
  • acute hemolytic anemia
    ±Þ¼º ¿ëÇ÷¼º ºóÇ÷(¡­éÁúìàõÞ¸úì).
  • acute hemolytic transfusion reaction
    ±Þ¼º¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • acute hemorrhagic conjunctivitis
    ±Þ¼ºÃâÇ÷°á¸·¿°
  • acute hemorrhagic conjunctivitis
    ±Þ¼ºÃâÇ÷¼º°á¸·¿°
  • acute hemorrhagic cystitis
    ±Þ¼º ÃâÇ÷¼º ¹æ±¤¿°
  • acute hemorrhagic pancreatitis
    ±Þ¼º ÃâÇ÷¼º ÃéÀå¿°(¡­õóúìàõõýíôæú).
  • acute hepatic insufficiency
    ±Þ¼º °£ºÎÀü.
  • acute hepatitis
    ±Þ¼º °£¿°
  • acute herpetic gingivostomatitis
    ±Þ¼ºÆ÷Áø¼º Ä¡Àº±¸³»¿°, ±Þ¼ºÇ츣Æä½º Ä¡Àº±¸³»¿°
  • acute hydramnion
    ±Þ¼º ¾ç¼ö°ú´Ù(Áõ)(¡­åÏâ©Î¦Òýñø).
  • acute hydrocephaly
    ±Þ¼º ¼öµÎÁõ(¡­â©Ôéñø).
  • acute hydrops
    ±Þ¼º¼öÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
ALL Acute Lymphocytic Leukemia
  ÇüÅÂÇÐÀû ºÐ·ù
    L1; Small, Homogenous(...
AMS Acute Mountain Sickness
AOM Acute Otitis Media
APM Acute Purulent Meningitis
APN Acute Pyelo-Nephritis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
APACHE II Acute Physiology and Chronic Health Evaluation II
APMPPE Acute Posterior Multifocal Placoid Pigment Epitheliopathy
APSGN Acute Poststreptococcal Glomerulonephritis
APL Acute Promyelocytic Leukaemia
AR Acute Rejection
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute pain
    ±Þ¼º ÅëÁõ, ±Þ¼º µ¿Åë
    1. À¯¹ß ÀÎÀÚ³ª ¿øÀÎ ÀÎÀÚµéÀÌ Á¤»óÀ¸·Î µÇ´Âµ¥ ÇÊ¿äÇÑ ½Ã°£À̳ª Á¤»óÀûÀÎ Ä¡À¯ ±â°£ ³»¿¡ Á¦ÇÑµÇ¾î ³ªÅ¸³ª´Â ºÒÄèÇÑ °¨°¢. ÀüÅëÀûÀÎ Á¤ÀÇ¿¡ ÀÇÇϸé 6°³¿ù ¹Ì¸¸ÀÇ ±â°£ÀÌ´Ù. 2. ª°í ºñ±³Àû ½ÉÇÑ ÇüÅÂÀÇ µ¿Åë.
  • acute pathologic pain
    ±Þ¼º º´¸®Àû µ¿Åë
  • acute periapical infection
    ±Þ¼º Ä¡±Ù´Ü °¨¿°
  • acute perichondritis
    ±Þ¼º ¿¬°ñ¸·¿°
  • acute periodontal abscess
    ±Þ¼º Ä¡ÁÖ ³ó¾ç
  • acute peritonitis
    ±Þ¼º º¹¸·¿°
    ¼¼±ÕÀÇ Ä§¹üÀ̳ª È­ÇÐÀû Àڱؿ¡ ÀÇÇØ¼­ »ý±æ ¼öµµ ÀÖÀ¸³ª °¡Àå ÈçÇÑ ¿øÀÎÀº ±Þ¼º Ãæ¼ö¿°À̳ª ¼ÒÈ­¼º ±Ë¾ç¿¡ ÀÇÇÑ Ãµ°ø µî ³»°­ÀÌ ÀÖ´Â Àå±âÀÇ Ãµ°ø¿¡ ÀÇÇÑ ¼¼±Õ¼º º¹¸·¿°ÀÌ´Ù. °ÅÀÇ Ç×»ó ³»Àå º®À» ÅëÇÑ ¼¼±ÕÀÇ ÆÄ±Þ ¶Ç´Â ³»ºÎ Àå°üÀÇ ÆÄ¿­¿¡ ÀÇÇØ ÀÌÂ÷ÀûÀ¸·Î »ý±ä´Ù.
  • acute pharyngitis
    ±Þ¼º Àεο°
    ±¸Çù, ÀεÎÀÇ Á¡¸· ¹× ¸²ÇÁ Á¶Á÷ÀÇ ±Þ¼º ¿°ÁõÀÌ´Ù. ¹ÙÀÌ·¯½º, ¼¼±Õ °¨¿°, ¶Ç ¹°¸®È­ÇÐÀû Àڱؿ¡ ÀÇÇØ¼­ »ý±ä´Ù. Áõ»óÀº °æµµ ¶Ç´Â ÁߵÀÇ ¹ß¿­, ÀεÎÀÇ ºÒÄè°¨ ³»Áö ÀεÎÅë µîÀÌ´Ù. ÀεΠÁ¡¸·Àº ¹ßÀû Á¾Ã¢ÇÏ°í ¾ÇÇÏ ¸²ÇÁÀý Á¾Ã¢À» ¼ö¹ÝÇÑ´Ù. ÇÕº´ÁõÀÌ ¾øÀ¸¸é °æ°ú´Â ¾çÈ£ÇÏ°í ¼öÀÏ¿¡¼­ 1ÁÖÀÏ Á¤µµ·Î Ä¡À¯ÇÑ´Ù. Ä¡·á´Â ¾ÈÁ¤, ÇÔ¼ö³ª ÈíÀÔ¿ä¹ý, ¼Ò¿°Á¦, Ç×»ý ¹°ÁúÀÇ Åõ¿© µîÀÌ´Ù.
  • acute phase protein
    ±Þ¼º±â ´Ü¹éÁú
    °¨¿°À̳ª Á¶Á÷ ¼Õ»óÀÌ ÀÖÀ» ¶§ Á¤»óº¸´Ù 2-100¹è Á¤µµ Áõ°¡ÇÏ´Â Ç÷Àå ´Ü¹éÁúÀ» ÃÑĪÇÏ¿© APP¶ó°í ÇÏ¸ç ¼±Ãµ¼º ¸é¿ª¿¡ °ü¿©ÇÑ´Ù.
  • acute phase reaction
    ±Þ¼º±â ¹ÝÀÀ
  • acute phase serum
    ±Þ¼º º´±â Ç÷û
  • acute pneumonia
    ±Þ¼º Æó·Å
    ¹ÙÀÌ·¯½º, ¼¼±Õ µî¿¡ ÀÇÇØ¼­ »ý±â´Â Æó ½ÇÁúÀÇ ±Þ¼º ¿°ÁõÀÌ°í º´º¯ÀÇ Áß½ÉÀº ÆóÆ÷ »óÇÇ, ¼¼Æ÷ °­¿¡ ÀÖÀ¸¸ç, ÆóÆ÷³»¿¡ ´Ù·®ÀÇ Ä§Ãâ¹°ÀÌ Ãæ¸¸ÇØ X-¼± Çʸ§ »ó¿¡¼­´Â ±â°üÁö °­À» Á¦¿ÜÇÏ°í ±ÕµîÇÑ ±×¸²ÀÚ·Î µÚµ¤ÀδÙ. Àü¿¡´Â °¨¿° Áúȯ Áß »óÀ§¸¦ Â÷ÁöÇϰí ÀÖ¾ú´Âµ¥ Ç×»ý ¹°ÁúÀÇ µîÀåÀ¸·Î °Ý°¨Çß´Ù. ÃÖ±Ù¿¡´Â ¿ø³»°¨¿°¿¡ µû¸¥ ³­Ä¡ÀÇ ±×¶÷ À½¼º±Õ °¨¿°ÀÌ Áõ°¡ Ãß¼¼¿¡ ÀÖ´Ù.
  • acute poliomyelitis
    ±Þ¼º ȸ¹éô¼ö¿°, ±Þ¼º ¼Ò¾Æ¸¶ºñ
    »ê¹ßÀûÀ¸·Î ¹ß»ýÇÏ´Â ±Þ¼º ¹ÙÀÌ·¯½º ÁúȯÀ¸·Î ¹ß¿­, ÀεΠ¹ßÀû, µÎÅë, ±¸Åä µîÀ» Ư¡À¸·Î ÇÏ°í ¸ñ´ú¹Ì¿Í µî ÂÊ ºÎºÐÀÇ °­Á÷À» µ¿¹ÝÇÑ´Ù.
  • acute poststreptococcal glomerulonephritis
    ±Þ¼º ¿¬¼â»ó ±¸±Õ¼º »ç±¸Ã¼ ½Å¿°
    A±º ¿¬¼â»ó ±¸±Õ °¨¿°ÀÌ ¿øÀÎÀÌ µÇ¾î ¹ß»ýÇÏ´Â ±Þ¼º ½Å¿°ÀÌ´Ù. ¿¬¼â»ó ±¸±Õ¿¡ ÀÇÇÑ Æíµµ¿° µîÀÌ Ä¡À¯µÇ¾î¼­ 1-2ÁÖ ÈÄ¿¡ µ¹¿¬ ºÎÁ¾, ÇÌ´¢, °íÇ÷¾Ð µîÀ» µ¿¹ÝÇØ¼­ ¹ßº´ÇÑ´Ù. ¼Ò¾Æ¿¡ ¸¹ÀÌ ¹ßº´Çϳª ¼ºÀο¡°Ôµµ µå¹°Áö´Â ¾ÊÀ¸¸ç, ¾à 90%´Â 1-2°³¿ù ÈÄ¿¡ ¿ÏÀüÈ÷ Ä¡À¯µÈ´Ù. Ç÷û ASLO °ªÀÇ »ó½Â°ú Ç÷û º¸Ã¼°¡ÀÇ °¨¼Ò°¡ Áø´Ü¿¡ µµ¿òÀÌ µÈ´Ù. ÀÌ Áõ»óÀº ¿¬¼â»ó ±¸±ÕÀÇ Ç׿ø°ú ±× Ç×ü¿¡ ÀÇÇÑ ¸é¿ª º¹ÇÕü ½Å¿°ÀÌ´Ù. ƯÈ÷ ¼Ò¾Æ¿¡¼­´Â ±Þ¼º±â¿¡ °íÇ÷¾Ð¿¡ ÀÇÇÑ ½ÉºÎÀü, °æ·ÃÀ» ÀÏÀ¸Å°±â ½±±â ¶§¹®¿¡ ÁÖÀǸ¦ ¿äÇÑ´Ù.
  • acute pseudomembranous candidosis
    ±Þ¼º À§¸·¼º ĵµð´ÙÁõ
  • acute psychologic distress
    ±Þ¼ºÀÇ Á¤½ÅÀû °íÅë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
acute parenchymatous hepatitis A lesion in which there is extensive and rapid death of parenchymal cells of the liver, sometimes with fatty degeneration of the size of the organ; the necrosis may result from fulminant viral infection or chemical poisoning; associated with jaundice.
Synonym: acute parenchymatous hepatitis, Rokitansky's disease.
(05 Mar 2000)
acute-phase protein <haematology> These plasma proteins (in addition to fibrinogen) increase 25% or more in response to inflammation and injury are under direct control of interleukin-6 (IL-6) (hepatocyte-stimulating factor).
Other proteins which increase are ceruloplasmin, C3 and C4 which increase 50% or more; alpha-1 acid glycoprotein, alpha-1 antitrypsin, haptoglobin and fibrinogen (the major determinant of viscosity 1 ) which increase two- to fourfold; C-reactive protein (CRP) and serum amyloid A which increase several hundred-fold.
Despite long-held clinical opinion to the contrary, available data indicate that neither ESR nor measurement of specific acute-phase reactants are useful in excluding underlying infection or inflammation regardless of the pretest probability.
These proteins are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. They can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumour markers.
See also: amyloid, c-reactive protein, erythrocyte sedimentation rate, viscosity.
(25 Jun 1999)
acute-phase reaction <immunology, rheumatology> Refers to the changes in synthesis of certain proteins within the serum during an inflammatory response, which provides rapid protection for the host against microorganisms via non-specific defense mechanisms.
It consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma; the reaction is mediated by endogenous pyrogens, the hypothalamus, adrenal hormones, and other factors.
(12 Jul 2000)
acute porphyria <gastroenterology, haematology> A group of metabolic disorders that result from a disturbance in porphyrin metabolism, causing increased formation and excretion of porphyrin or its precursors.
Acute intermittent porphyria is a rare inherited (autosomal dominant) form that can result in abdominal pain, photosensitivity and neurological disturbances. The various forms can be differntiated measuring various blood prophyrins.
(27 Sep 1997)
acute post-streptococcal glomerulonephritis <nephrology> A disease of the kidneys that results in inflammation of the glomerulus (the portion of the kidney that filters the blood).
Conditions which may cause glomerulonephritis include post-streptococcal disease (strep throat), lupus, syphilis, bacterial endocarditis, membranoproliferative glomerulonephritis, sepsis, vasculitis, Goodpasture's syndrome, typhoid fever, Henoch-Schonlein purpura, hepatitis or a viral infection (for example mumps, measles, mononucleosis).
(27 Sep 1997)
acute primary haemorrhagic meningoencephalitis A disease characterised by acute onset of fever, followed by convulsions, delirium, and coma, and associated with perivascular demyelination and haemorrhagic foci in the central nervous system.
Synonym: acute primary haemorrhagic meningoencephalitis, Strumpell's disease.
(05 Mar 2000)
acute promyelocytic leukaemia Leukaemia presenting as a severe bleeding disorder, with infiltration of the bone marrow by abnormal promyelocytes and myelocytes, a low plasma fibrinogen, and defective coagulation.
(05 Mar 2000)
acute pulmonary alveolitis Acute inflammation involving exudate into the pulmonary alveoli and impaired gas exchange; may result in necrosis with haemorrhage into the lungs; occurs in Goodpasture's syndrome, in association with a glomerulonephritis.
(05 Mar 2000)
acute pulmonary eosinophilia <chest medicine> A self-limiting inflammation in the lungs where there is associated infiltration of eosinophils into lung tissue. Chest X-ray reveals pulmonary infiltrates and full blood count shows increased numbers of eosinophils.
The cause is unknown and the disease often resolves without treatment. Some forms may be treated with oral corticosteroids. Complications include restrictive cardiomyopathy due to fibrosis of the lining of the heart.
(27 Sep 1997)
acute pyelonephritis Acute inflammation of the renal parenchyma and pelvis characterised by small cortical abscesses and yellowish streaks in the medulla due to pus in the collecting tubules and interstitial tissue.
(05 Mar 2000)
acute radiation syndrome <syndrome> A syndrome caused by exposure of the body to large amounts of radiation, (e.g., from certain forms of therapy, accidents, and nuclear explosions; it is divided into three major forms which are, in ascending order of severity, the haematogic, gastrointestinal, and central nervous system-cardiovascular forms; its clinical manifestations are divided into prodromal, latent, overt, and recovery stages.
(05 Mar 2000)
acute reflex bone atrophy Atrophy of bones, commonly of the carpal or tarsal bones, following a slight injury such as a sprain.
See: causalgia, reflex sympathetic dystrophy.
Synonym: acute reflex bone atrophy, posttraumatic osteoporosis, Sudeck's syndrome.
Origin: L. English sweat
(05 Mar 2000)
acute rejection Graft rejection which usually begins within 10 days after a graft has been transplanted into a genetically dissimilar host. Lesions at the site of the graft characteristically are infiltrated with large numbers of lymphocytes and macrophages which cause tissue damage.
See: primary rejection.
Synonym: acute rejection.
(05 Mar 2000)
acute renal failure <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect).
Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
acute respiratory failure Loss of pulmonary function either acute or chronic that results in hypoxaemia or hypercarbia.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á